Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sorry below 3.0 NO more.
Can I expect it?
You are so much concerned about nothing burger that I don’t get.
Its hard to believe IR even mentions about stock price but I trust you and really hope that is the case. Thanks
Oh YEAH. Da man is back! Lol
Yes, that IS truly something!
100% gain VS 40% loss- certainly not a good risk/reward for BIIB
What a horror story..................... for shorts.
You are too funny.
That makes sense. Yes you are the 1st one.
sORRY i HAVE TO TELL YOU THAT i DON'T BELIEVE YOU, FULL OF JOKES,NON-SENSES.
I am happy too. It's value has reduced so much and 24% down today doesn't
affect my valance too much. I'm talking multi-million shares.
Thank you for sharing info.
It was needless to say. All know that.
It’s certainly unusual though I was never convinced his posting video is a signal to shorts.
I thought he posts stocks with a big gain for the day.
That’s A NEWS!!! Thanks
interesting report! thanks.
Good luck to you this time. I got in same time you did or little earlier got disappointed every year since then.
This tells a lot:
"Six of the patients also improved their MMSE scores significantly – an unprecedented outcome in Alzheimer’s treatment. This trial was extended from an initial six months to five years on the basis of the strength of the results and at the request of trial participants and their carers."
By Dr. McFarlane
A2-32 will stand out over BAN2401 for attendees.
They dare are going........
Wow he did not know Alzheimer's P2/3 takes the place of P3?
I thought he is a longtime follower of AVXL though I don’t know the point being......
You are very kind to all people; too kind to even those who are xxxxx. haha
What?!?! IV delivery? That's unreal for elderly AD patients.
Glad to hear from you saying 'no competition'.
Would you know if FDA allows means of delivery in the next phase in any trials?
I'm talking about even a possibility of their modifying way of delivery to 'oral'.
Thanks.
How will Biogen be able to announce a good results with brain swelling for 10% of patients??? I think that's a major side effect. Well, scientist don't think so?
Yes now I see it. : ) Thank you!
I suppose they did an extensive due deligiance before investing. : )
Hwow.....
Can you compare BAN2401 VS A2-32 in their MC of $12.5B VS $1.5 Mil?
Maybe you are a wrong person to ask but just be a devil's advocate.
If MTA just died he wouldn't say 'yes'. He can't.
You are making stuffs up. Lol
The records are to be broken. The link is very helpful.
Thanks to you and DD.
Hope Dr. M starts PR war next week.
I would hate BO but by the time they make an offer to Dr.M Anavex market cap would be $5 billions or $100 per share (just AD) assuming 100% buyout premium.
Just my today’s daydream.
Anyone has seen bigger buyout premium that 100%?
$6 billions up for a possibility of AD medicine with 10% patient getting brain swelling. Unbelievable..
If Anavex had a such pr, we’d lose shirt and pants.
Yes I like to see your estimate. Thank you for your posts.
I don’t care 10% loss, will see tomorrow.
Wow.... who is buying this hopeless company? 1.3 million shares
Why not? They were to start before EOY last year.
It was reasonable for me to expect all start in 1H.
We are now in 2H.
It is NOT a stretch to expect them all started before EOY.
You’re missing one. How bout better cholesterol level? lol
Your claim is just amazing.
I trust you for your rumor : ) as you are new to this board.
Odd. Current pps @ 3.82. Bid 3.90 ask 3.97.
Oh I get it. Stock exchange closed at 1:00 pm ETS today.
A.H pps at $3.87 now 3:45 pm
Powerful Leaping from $3.4 to 3.8.
Volume bar of 6 mil dwarfs the 4 mil a month ago!!
Finally exited and looking forward to hearing from AAIC conference this month.